Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore groundbreaking research in prion protein silencing through this keynote presentation from the Ladders to Cures Accelerator Symposium. Discover how AAV-mediated delivery of engineered compact epigenetic editors can achieve brainwide silencing of prion protein, representing a significant advancement in potential treatments for prion diseases. Learn about the innovative approach of using adeno-associated virus (AAV) vectors to deliver specialized epigenetic editing tools that can effectively silence target proteins throughout the brain tissue. Understand the technical challenges and solutions involved in developing scalable technologies for rare genetic diseases, particularly those affecting the central nervous system. Gain insights into the intersection of gene therapy, epigenetic editing, and neurodegenerative disease research as presented by leading researchers in the field. The presentation is part of a broader symposium focused on accelerating progress toward treatments and cures for patients with rare genetic diseases, bringing together scientists, physicians, patients, and industry experts to advance therapeutic development.
